Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101255171A reveals a safer carbapenem intermediate process eliminating toxic organotin. Achieve cost reduction and supply reliability.
Patent CN119039150A details a novel Negishi coupling route for high-purity Cobicistat intermediates, offering significant supply chain and cost advantages for manufacturers.
Patent CN106316935A details a green route for Abemaciclib intermediate. Offers high purity and scalable manufacturing for global supply chains.
Patent CN115947718A reveals a novel Pd-catalyzed coupling route for Lasmiditan intermediates, offering significant cost reduction and safer API manufacturing scalability.
Novel patent CN117924314A offers high-purity Relugolix intermediate synthesis with reduced impurities and scalable manufacturing for reliable pharmaceutical intermediate supplier partnerships.
Novel one-pot synthesis for Teneligliptin intermediate offers high purity and cost efficiency for pharmaceutical manufacturing supply chains globally.
Patent CN114380819B reveals safer zolpidem intermediate synthesis. Enhances supply chain reliability and reduces toxic reagent usage for pharmaceutical manufacturing.
Advanced synthesis of Pemetrexed disodium intermediate via amino protection. Reduces impurities, lowers costs in API manufacturing, and ensures high-purity supply.
Patent CN108129536A reveals waste-to-value synthesis improving yield and reducing environmental impact for reliable pharmaceutical intermediate supply chains.
Novel synthesis of Vilanterol intermediate CN105646285A offers higher yield and cost efficiency. Reliable pharmaceutical intermediates supplier for global supply chains.
Novel aldol condensation method for Donepezil key intermediate using toluene solvent, offering high purity and yield for industrial scale-up.
Patent CN102153512B reveals a mixed-acid hydrolysis method for Rebamipide intermediates, offering superior yield and purity for global supply chains.
Novel process for (1S)-4,5-dimethoxy-1-(methylaminomethyl)-benzocyclobutane synthesis offering superior yield and purity for reliable API intermediate supply chains.
Patent CN103467276B offers a safer route for Montelukast intermediates ensuring supply chain reliability and cost efficiency for pharmaceutical manufacturing partners globally.
Patent CN109942514A reveals efficient Ir-catalyzed route for Atazanavir intermediate. Enables cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN115947680B reveals a novel Tirofiban intermediate synthesis. Achieve higher purity and yield with reduced impurities for reliable pharmaceutical manufacturing.
Patent CN114057642B reveals a mild, high-yield synthesis for Mivacurium intermediates, offering significant cost reduction and safety improvements for API manufacturing.
Patent CN111333573A details a robust asymmetric hydrogenation process for dextromethorphan intermediates, offering superior enantioselectivity and scalable manufacturing advantages.
Patent CN102050791B discloses a cost-effective synthesis of telmisartan intermediates using mild conditions, offering supply chain stability and reduced production costs for global manufacturers.
Patent CN106749259B reveals a metal-free synthetic route for CDK4/6 inhibitor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.